National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report-Reference-Cited by-同舟云学术

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report

Published:2021-06 Issue:6 Volume:27 Page:452-466
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Williams Kirsten M.,Inamoto Yoshihiro,Im Annie,Hamilton Betty,Koreth John,Arora Mukta,Pusic Iskra,Mays Jacqueline W.,Carpenter Paul A.,Luznik Leo,Reddy Pavan,Ritz Jerome,Greinix Hildegard,Paczesny Sophie,Blazar Bruce R.,Pidala Joseph,Cutler Corey,Wolff Daniel,Schultz Kirk R.,Pavletic Steven Z.,Lee Stephanie J.,Martin Paul J.,Socie Gerard,Sarantopoulos Stefanie

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference143 articles.

1. The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease;Cooke;Biol Blood Marrow Transplant,2017

2. The science and medicine of human immunology;Pulendran;Science,2020

3. Mouse models of graft-versus-host disease: advances and limitations;Schroeder;Dis Model Mech,2011

4. Emergent autoimmunity in graft-versus-host disease;Tivol;Blood,2005

5. Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity;Dertschnig;J Clin Invest,2020

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention;Blood Advances;2024-08-15

2. Vaginal complications of graft-versus-host disease after hematopoietic stem cell transplantation: a cross-sectional study;Annals of Medicine & Surgery;2024-05-22

3. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development;Current Oncology;2024-03-08

4. Ocular and Oral Complications;The EBMT Handbook;2024

5. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death;Journal of Clinical Investigation;2023-08-01